The United States is not taking a leading role in the international response to a deadly Ebola outbreak in Central and East Africa.
This lack of leadership concerns public health experts who argue that the U.S. has historically served as a pioneer in fighting infectious diseases. Without a coordinated American effort, the ability to contain the virus across borders may be compromised.
According to the World Health Organization, health workers are racing to contain the virus in regions including the Democratic Republic of Congo [1]. The outbreak has killed more than 100 people [1] and infected almost 570 [1].
Critics said the U.S. is currently playing catch-up with the crisis [2]. This delay is attributed to several systemic issues, including funding gaps, limited readiness, and restrictive travel policies [3, 4].
Concerns have also emerged regarding the treatment of American citizens exposed to the virus. Reports indicate the administration has considered sending exposed Americans to Kenya rather than repatriating them for treatment [5].
In a related move, the White House paused the removal of detainees from the Democratic Republic of Congo due to the outbreak [6]. This decision highlights the volatility of the region as health agencies attempt to manage the spread of the disease.
"The United States, once a pioneer in the worldwide fight against infectious disease, is now playing catch‑up with a deadly Ebola outbreak," an opinion author wrote in The Hill [2].
Public health agencies, including the CDC, remain involved in monitoring the situation, but the current level of engagement is described as insufficient to lead a global response [2, 7].
“The United States, once a pioneer in the worldwide fight against infectious disease, is now playing catch‑up”
The shift in the U.S. approach to global health emergencies suggests a move away from the proactive, leadership-heavy model used in previous decades. By prioritizing restrictive travel policies and avoiding repatriation, the U.S. risks creating a vacuum in international health governance, potentially slowing the global containment of highly infectious diseases.
